InvestorsHub Logo
Followers 59
Posts 9079
Boards Moderated 0
Alias Born 08/20/2000

Re: None

Wednesday, 03/13/2002 12:46:14 PM

Wednesday, March 13, 2002 12:46:14 PM

Post# of 18
Global Innovative Systems, Inc. Announces Share Buy Back Plan

LAS VEGAS, March 12 /PRNewswire-FirstCall/-- Global Innovative Systems, Inc. (OTC Bulletin Board: GBIS - news), a Nevada Corporation, announces today that it plans to buy back up to 20% of its 9,500,000 common shares that are in the float.


Purchases may be made from the open market at prevailing market prices. The number of shares of common stock actually purchased by the Company will depend on subsequent developments and corporate needs, and the buy back of shares may be cancelled at any time.

At current prices, we feel that our stock is undervalued, Global Innovative Systems, Inc., by reducing the size of the float, we hope to achieve a more realistic value between the stock valuation and the company's performance to date and to enhance shareholder value in the long run.

About Global Innovative Systems, Inc.

The ``Enermed Therapy' is an innovative electrode-less technology that, prior to the pilot study with MS, was used primarily to treat migraine headaches. The technology allows a trained technician to take a reading of the amplitude of the bioelectromagnetic signals emitted by individual patients. The Enermed Device, a non-invasive, pulsed electromagnetic field generator is then programmed based on each patient's own bioelectromagnetic profile. The electromagnetic energy generated by the Enermed is similar in strength to the electromagnetic field produced by the earth.

The 1997 pilot study and the more recent multi-site clinical trial of the Enermed demonstrated the Company's commitment to completing the research required for FDA approval of this therapy. A non-pharmacological treatment for the symptoms of MS would be a tremendous breakthrough for the MS community. It is estimated that 350,000 people in the United States and up to 2 million people worldwide suffer from MS. The National Multiple Sclerosis Society estimates that direct and indirect costs associated with MS exceed 9 billion dollars annually.

For more information on the Enermed Therapy for the symptomatic relief of MS and Migraine headaches visit the Company's website at www.enermed.com, to schedule an appointment call 1-866ENERMED.

SOURCE: Global Innovative Systems, Inc.

.

.......According to the Great Pumpkin, ".....You're in .....iHub....., Charlie Brown....."!!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.